Clinical Trials in Philadelphia

Showing 20621-20640 of 20,904 trials

UNKNOWNPhase 4< 1 mile

A Pharmacokinetic Study of Actinomycin-D and Vincristine in Children With Cancer

NCT00491946

To obtain a preliminary characterization of the plasma PK and metabolites of actinomycin-D in children with cancer.

Cancer

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)24 participantsStarted Jun 2004

Philadelphia, Pennsylvania, United States

TERMINATEDPhase 1< 1 mile

Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia

NCT00105313

For primary objectives, we will determine the MTD and examine clinical responses and immune cell populations to determine an OBD, and describe the safety and tolerability of MEDI-507. For the secondary objectives we will look at the antitumor activity of MEDI 507, PK, serum concentrations, and immunogenicity of MEDI-507, as well as time courses of depletion and recovery of CD2 positive and total T-Cell populations.

LymphomaLeukemiaCancer

MedImmune LLC80 participantsStarted Feb 2005

Los Angeles, California, United States • New Haven, Connecticut, United States • Washington D.C., District of Columbia, United States +8 more locations

TERMINATEDPhase 3< 1 mile

Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

NCT00243204

This Phase 3 study will compare the efficacy of talabostat plus docetaxel to docetaxel plus placebo in patients with Stage IIIB/IV NSCLC who have failed a platinum-based chemotherapy regimen.

Carcinoma, Non-Small Cell Lung

Point Therapeutics400 participantsStarted Jan 2006

Huntsville, Alabama, United States • Muscle Shoals, Alabama, United States • Anchorage, Alaska, United States +93 more locations

A Pharmacokinetic Study of Actinomycin-D and Vincristine in Children With Cancer

Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia

Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Find Trials by Condition in Philadelphia

Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

DTaP and Apnea/Bradycardia in Preterm Infants

12 Week Evaluation of the Safety and Efficacy of a Flexible Dose of CP-526,555 and Placebo for Smoking Cessation

Effects of LY450139 Dihydrate on Subjects With Mild to Moderate Alzheimer's Disease

Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)

A Study for the Treatment of Mania Associated With Bipolar I Disorder in Children and Adolescents

Olanzapine Versus Placebo in the Treatment of Adolescents With Schizophrenia

Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder

CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) Remission

MLN2704 in Subjects With Metastatic Androgen-Independent Prostate Cancer

Comparison of Two Growth Hormone Dosing Methods in Adults With Growth Hormone Deficiency

A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation

Study Comparing Racivir and Lamivudine in Treatment-Experienced HIV Subjects

Study to Evaluate the Human Infection of the Lower Respiratory Tract in Children at High Risk

Acupuncture for the Treatment of Chronic Daily Headaches

Phase 2 Study of the Safety and Efficacy of UK-500,001 in Adult Patients With COPD

Urge Incontinence Bladder Overactivity Study